La biologie des cancers bronchiques et les nouvelles cibles thérapeutiques : état des connaissances et perspectives = Rational and innovative treatments for lung cancer: overview of new approaches and perspectivesDELORD, J.-P; CAUNES, N.Oncologie (Paris). 2002, Vol 4, Num 4, pp 285-291, issn 1292-3818Article

Clinical activity of patupilone in patients with pretreated advanced/ metastatic colon cancer: results of a phase I dose escalation trialMELICHAR, B; CASADO, E; SGUOTTI, C et al.British journal of cancer. 2011, Vol 105, Num 11, pp 1646-1653, issn 0007-0920, 8 p.Article

Dexamethasone as a probe for CYP3A4 metabolism: evidence of gender effectPUISSET, F; CHATELUT, E; SPARREBOOM, A et al.Cancer chemotherapy and pharmacology. 2007, Vol 60, Num 2, pp 305-308, issn 0344-5704, 4 p.Article

A phase Ib dose-escalation study of erlotinib, capecitabine and oxaliplatin in metastatic colorectal cancer patientsVAN CUTSEM, E; VERSLYPE, C; BEALE, P et al.Annals of oncology. 2008, Vol 19, Num 2, pp 332-339, issn 0923-7534, 8 p.Article

Thérapeutiques ciblées et cancers du côlon = Target therapies and colon cancersBUGAT, R; DELORD, J.-P.Oncologie (Paris). 2003, Vol 5, Num 7-8, pp 369-373, issn 1292-3818, 5 p.Article

Toxicité dermatologique des nouvelles thérapies ciblées anticancéreuses utilisées en oncodermatologie = Dermatologic adverse events of the new targeted anticancer therapies used in oncodermatologySIBAUD, V; DELORD, J.-P; CHEVREAU, C et al.Annales de chirurgie plastique et esthétique. 2012, Vol 57, Num 2, pp 106-113, issn 0294-1260, 8 p.Article

Choriocarcinome placentaire métastatique chez la mère et son nouveau né : à propos d'un cas = Metastatic placental choriocarcinoma to mother and newborn : a case reportMAILLY, N; DELORD, J.-P; DUBOIS, A et al.Journal de radiologie (Paris). 2008, Vol 89, Num 4, pp 517-520, issn 0221-0363, 4 p.Article

Spermatic cord sarcoma in adultsMERIMSKY, O; TERRIER, P; BONVALOT, S et al.Acta oncologica (Stockholm). 1999, Vol 38, Num 5, pp 635-638, issn 0284-186XArticle

6-day continuous infusion of high-dose ifosfamide with bone marrow growth factors in advanced refractory malignanciesBRAIN, E. C. G; MITA, A; MISSET, J.-L et al.Journal of cancer research and clinical oncology. 1997, Vol 123, Num 4, pp 227-231, issn 0171-5216Article

Évidement cervical systématique dans les cancers épidermoïdes de la cavité orale = Systematic neck dissection in squamous cell carcinoma of the oral cavityBENLYAZID, A; SARINI, J; MARQUES, B et al.Annales d'oto-laryngologie et de chirurgie cervico-faciale. 2007, Vol 124, Num 6, pp 285-291, issn 0003-438X, 7 p.Article

Population pharmacokinetics of oxaliplatinDELORD, J.-P; UMLIL, A; GUIMBAUD, R et al.Cancer chemotherapy and pharmacology. 2003, Vol 51, Num 2, pp 127-131, issn 0344-5704, 5 p.Article

Le cancer du rein de l'adulte = Adult renal cell carcinomaDELORD, J.-P; ALEXANDRE, J; CHEVREAU, C et al.Bulletin du cancer. 1998, Vol SEP, pp 4-15, issn 0007-4551, SUP1Article

Effets secondaires cutanés des nouvelles molécules anticancéreuses : focus sur les molécules ciblant les récepteurs tyrosine kinase et le récepteur à l'EGF = Cutaneous side effects associated with epidermal growth factor receptor and tyrosine kinase inhibitorsDESLANDRES, M; SIBAUD, V; CHEVREAU, C et al.Annales de dermatologie et de vénéréologie. 2008, Num JANV, pp 16-24, issn 0151-9638, 9 p., HSArticle

Primary sarcomas of the central nervous systemMERIMSKY, O; LEPECHOUX, C; TERRIER, P et al.Oncology. 2000, Vol 58, Num 3, pp 210-214, issn 0030-2414Article

Phase I dose-escalation study of oral vinflunine administered once daily for 6 weeks every 8 weeks in patients with advanced/metastatic solid tumoursDELORD, J. P; TOURANI, J. M; LEFRESNE, F et al.Cancer chemotherapy and pharmacology. 2013, Vol 71, Num 3, pp 647-656, issn 0344-5704, 10 p.Article

Carcinocythemia as the single extension of breast cancer : Report of a case and review of the literatureSERONIC-VIVIEN, S; MERY, E; DELORD, J. P et al.Annals of oncology. 2001, Vol 12, Num 7, pp 1019-1022, issn 0923-7534Article

Phase I and pharmacokinetic study of IV vinflunine in cancer patients with liver dysfunctionDELORD, J. P; RAVAUD, A; BENNOUNA, J et al.Investigational new drugs. 2013, Vol 31, Num 3, pp 724-733, issn 0167-6997, 10 p.Article

A phase I clinical and pharmacokinetic study of capecitabine (Xeloda®) and irinotecan combination therapy (XELIRI) in patients with metastatic gastrointestinal tumoursDELORD, J. P; PIERGA, J. Y; MERY-MIGNARD, D et al.British journal of cancer. 2005, Vol 92, Num 5, pp 820-826, issn 0007-0920, 7 p.Article

A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignanciesDELORD, J. P; RAYMOND, E; PAUTIER, P et al.Annals of oncology. 2000, Vol 11, Num 1, pp 73-79, issn 0923-7534Article

Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase 1/11 ADVANTAGE trial (phase II part)VERMORKEN, J. B; PEYRADE, F; BRÜMMENDORF, T. H et al.Annals of oncology. 2014, Vol 25, Num 3, pp 682-688, issn 0923-7534, 7 p.Article